Evidence map›Paper›PMID 27812296›Full record

ReviewClinical medicine insights. Gastroenterology2016

Diagnostic and Therapeutic Approaches to Hepatocellular Carcinoma: Understanding the Barcelona Clínic Liver Cancer Protocol.

Jonathan Soldera, Silvana Sartori Balbinot, Raul Angelo Balbinot, Andreza Gautério Cavalcanti

Abstract readReview
In one paragraph

Review in Clinical medicine insights. Gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jonathan SolderaProfessor, Faculty of Medicine, Universidade de Caxias do Sul, Caxias do Sul, Rio Grande do Sul, Brazil; Master's in Hepatology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
Silvana Sartori BalbinotProfessor, Faculty of Medicine, Universidade de Caxias do Sul, Caxias do Sul, Rio Grande do Sul, Brazil; Doctorate in Clinical Gastroenterology, Universidade de São Paulo, São Paulo, Brazil.
Raul Angelo BalbinotProfessor, Faculty of Medicine, Universidade de Caxias do Sul, Caxias do Sul, Rio Grande do Sul, Brazil; Doctorate in Clinical Gastroenterology, Universidade de São Paulo, São Paulo, Brazil.
Andreza Gautério CavalcantiResident Physician, Department of Gastroenterology, Hepatology and Digestive Endoscopy, Hospital Geral de Caxias do Sul, Caxias do Sul, Rio Grande do Sul, Brazil; Internal Medicine, Hospital Geral de Caxias do Sul, Caxias do Sul, Rio Grande do Sul, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Each year, hepatocellular carcinoma is diagnosed in more than half a million people worldwide and it is the fifth most common cancer in men and the seventh most common cancer in women. This article reviews the Barcelona-Clínic Liver Cancer protocol for the diagnosis, staging, and treatment of this disease, and four cases are presented for the discussion of the therapeutic approach. Understanding the diagnostic and therapeutic approaches to this disease is essential, especially if we keep in mind the quintessential basics of prevention and early detection.

Indexed as

hepatocellular carcinomaliver cirrhosisneoplasm staging

Identifiers

PMID27812296
PMCPMC5084833

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.